Pomegranate Improve Biological Recovery Kinetics in Elite Weightlifter
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02697903 |
Recruitment Status :
Completed
First Posted : March 3, 2016
Last Update Posted : March 3, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Healthy | Dietary Supplement: Natural Pomegranate Juice Dietary Supplement: Placebo Juice | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 9 participants |
Allocation: | Non-Randomized |
Intervention Model: | Crossover Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | Pomegranate Supplementation Accelerates the Recovery Kinetics of Muscle Damage, Muscle Soreness and Inflammatory Marker After Weightlifting Training Session. |
Study Start Date : | January 2015 |
Actual Primary Completion Date : | February 2015 |
Actual Study Completion Date : | February 2015 |
Arm | Intervention/treatment |
---|---|
Experimental: 9 elite weightlifters
age: 21 ± 0.5 years, body mass: 80 ± 20 kg, height 175 ± 8.1 cm (mean ± SD). They received "Natural Pomegranate Juice" supplementation during and 48h following the first weightlifting training session.
|
Dietary Supplement: Natural Pomegranate Juice
Supplements (1500ml) of pomegrenate juice (POMj) were taken three times daily in the 48h which proceed the first tested training sessions (i.e. 250ml × 6 times with 8-h intervals between it). Moreover, during this tested sessions, subject consumed an additional 500ml of POMj. Arm-specific: Experimental: 9 elite weightlifter |
Placebo Comparator: 9elite weightlifters
age: 21 ± 0.5 years, body mass: 80 ± 20 kg, height 175 ± 8.1 cm (mean ± SD). They received "Placebo Juice" supplementation during and 48h following the second weightlifting training session.
|
Dietary Supplement: Placebo Juice
Supplements (1500ml) of Placebo juice (PLA) were taken three times daily in the 48h which proceed the second tested training sessions (i.e. 250ml × 6 times with 8-h intervals between it). Moreover, during this tested sessions, subject consumed an additional 500ml of POMj. Arm-specific: Placebo Comparator: 9 elite weightlifter |
- Change in physical performance from using Placebo to using Pomegranate juice [ Time Frame: 3min after Placebo and Pomegranate training sessions ]The performance in each session was measured by the total volume lifted in the two Olympic movements (volume lifted (kg) in snatch added volume lifted (kg) in clean and Jerk: only the right lifts are taken into consideration) and by the maximal power lifted amounts in both Olympic movement (i.e., the maximal load lifted (kg) in the power snatch added to the maximal load lifted (kg) in the power clean and Jerk)
- Change in Acute Hematological responses from using Placebo to using Pomegranate juice [ Time Frame: 3min after Placebo and Pomegranate training sessions ]Haematological parameters (i.e., white blood cells (WBC), neutrophils (NEU), red blood cells (RBC), hemoglobin (HGB), hematocrit (HCT)and platelets (PLT) were generally performed within 3 h of blood sampling in a multichannel automated blood cell analyser Beckman Coulter Gen system-2 (Coulter T540)
- Change in Acute Biochemical responses from using Placebo to using Pomegranate juice [ Time Frame: 3min after Placebo and Pomegranate training sessions ]Glycemia (GLY), Creatinine (CRE), muscle damage markers (Creatinine kinase (CK), Alkaline phosphate (PAL), Gammaglutamyl (GGT), Lactate dehydrogenase (LDH)) and c-reactive protein (CRP) were determined spectrophotometrically using Abott Architect Ci 4100
- Change in Delayed Hematological responses from using Placebo to using Pomegranate juice [ Time Frame: 48h after Placebo and Pomegranate training sessions ]Haematological parameters (i.e., white blood cells (WBC), neutrophils (NEU), red blood cells (RBC), hemoglobin (HGB), hematocrit (HCT)and platelets (PLT) were generally performed within 3 h of blood sampling in a multichannel automated blood cell analyser Beckman Coulter Gen system-2 (Coulter T540)
- Change in Delayed Biochemical responses from using Placebo to using Pomegranate juice [ Time Frame: 48h after Placebo and Pomegranate training sessions ]Glycemia (GLY), Creatinine (CRE), muscle damage markers (Creatinine kinase (CK), Alkaline phosphate (PAL), Gammaglutamyl (GGT), Lactate dehydrogenase (LDH)) and c-reactive protein (CRP) were determined spectrophotometrically using Abott Architect Ci 4100
- Change in the acute fatigue perception (RPE values) from Placebo to Pomegranate supplementation [ Time Frame: 3min after Placebo and Pomegranate training sessions ]The RPE scale (15-points) runs from 6 (very, very light) to 20 (very, very hard) 10. RPE scale measures feelings of effort, strain, discomfort, and/or fatigue experienced during physical task. Although this is a subjective measure (person's exertion), RPE values were shown to provide good estimation of the increase in heart rate, muscle fatigue and several other physiological measures during physical activity
- Change in the delayed muscle soreness (DOMS values) from Placebo to Pomegranate supplementation [ Time Frame: 48 after Placebo and Pomegranate training sessions ]Delayed onset soreness (DOMS) of the knee extensor and elbow flexor was determined 48 hours after training sessions. 48h after each training session, participants were asked to rate subjectively the degree of soreness in both muscles using a visual analog scale of 0 (absence of soreness) to 10 (unbearable soreness) [28]. Soreness was normalized to 100% of the maximal perceived level.
- Change in the acute oral temperature response from Placebo to Pomegranate supplementation [ Time Frame: 3min after Placebo and Pomegranate training sessions ]oral temperature was recorded with a calibrated digital clinical thermometer (Omron, Paris, France; accuracy: 0.05°C) inserted sublingually for at least 3 min with the subjects in a seated resting position
- Change in the acute Heart rate ( HR) response from Placebo to Pomegranate supplementation [ Time Frame: 3min after Placebo and Pomegranate training sessions ]heart rate (HR) was recorded using a heart rate monitor
- Change in the acute systolic arterial pressure (SAP) response from Placebo to Pomegranate supplementation [ Time Frame: 3min after Placebo and Pomegranate training sessions ]systolic arterial pressure (SAP) was recorded using a manual sphygmomanometer
- Baseline values of body mass [ Time Frame: at baseline status ]
- baseline values of height [ Time Frame: at baseline status ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years to 24 Years (Adult) |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- trained at least five sessions per week with 90 to 120 min per session
- had an experience of more than 3 years in Olympic weightlifting
Exclusion Criteria:
- use any antioxidant (e.g., vitamin E, A, C etc..) or anti-inflammatory during the experimentation period and one month before
- had injuries during the experimentation period and one month before

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02697903
Tunisia | |
Achraf | |
Sfax, Tunisia, 3000 |
Principal Investigator: | Achraf Ammar, Dr | Institute of sport and physical education of Sfax, Tunisia |
Responsible Party: | Ammar Achraf, Dr, The Higher Institute of Sport and Physical Education of Sfax |
ClinicalTrials.gov Identifier: | NCT02697903 |
Other Study ID Numbers: |
16-2015 |
First Posted: | March 3, 2016 Key Record Dates |
Last Update Posted: | March 3, 2016 |
Last Verified: | March 2016 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | Data will be shared with researchers outside the primary research group for reanalysis purpose. |
Creatine kinase supplementation C-reactive protein resistance training |
Pomegranate supplementation pomegranate juice muscle damage response |